Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 922-435-3 | CAS number: -
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In vitro genetic toxicity studies have been conducted on three substances in the TDI-I category. Bacterial reverse mutation assays (Ames tests) have been conducted with Diurea 8 (Bowles 2012), Tetraurea 2 (Thompson 2011), and the reaction product of m-tolylidene diisocyanate, cyclohexylamine, cyclohex-1,2-ylenediamine and (Z)-octadec-9 -enylamine (Escarti 2010). In all tests no significant increases in the frequency of revertant colonies were recorded for any of the strains of bacteria at any dose level, up to the maximum recommended, either with or with metabolic activation. Therefore, the three test items are non-mutagenic under the conditions of the test, and thus the other TDI-I category members are also considered to be non-mutagenic.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
PU TDI-I substances all contain the same core structure, with predominantly linear alkyl chains (C8 – C18) attached. The same substance can contain structures with different alkyl chain lengths, and some substances may contain small amounts of structures with cyclic groups. PU TDI-I structures are therefore similar between all category members, and organisms will be exposed to very similar compounds. Organisms would be exposed to common structures, only differing by the length of the alkyl chain or whether cyclic groups are present. In the body, there may be metabolism of the PU TDI-I structures, however due to the structural similarity of the parent compounds any metabolites are also likely to be similar.
Justification for classification or non-classification
Bacterial reverse mutation assays (Ames tests) have been conducted on three substances in the TDI-I category (Bowles 2012, Escarti 2010 and Thomson 2011). In all tests no significant increases in the frequency of revertant colonies were recorded for any of the strains of bacteria at any dose level, up to the maximum recommended, either with or with metabolic activation. Therefore, the three test items are non-mutagenic under the conditions of the test, and thus the TDI-I category members are also considered to be non-mutagenic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
